CNO — California Nanotechnologies Cashflow Statement
0.000.00%
- CA$26.63m
- CA$28.83m
- $3.34m
- 77
- 33
- 13
- 35
Annual cashflow statement for California Nanotechnologies, fiscal year end - February 29th, USD millions except per share, conversion factor applied.
2020 February 29th | 2021 February 28th | 2022 February 28th | 2023 February 28th | 2024 February 29th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -0.056 | -0.121 | 0.201 | 0.08 | 0.382 |
Depreciation | |||||
Non-Cash Items | 0.027 | -0.051 | 0.023 | 0.158 | 0.545 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 0.037 | 0.066 | -0.209 | 0.243 | -0.968 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Accounts Payable | |||||
Change in Payable / Accrued Expenses | |||||
Change in Taxes Payable | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | 0.136 | 0.025 | 0.144 | 0.623 | 0.104 |
Capital Expenditures | 0 | — | -0.008 | -0.086 | -0.014 |
Purchase of Fixed Assets | |||||
Cash from Investing Activities | 0 | — | -0.008 | -0.086 | -0.014 |
Financing Cash Flow Items | — | — | -0.061 | -0.197 | -0.088 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -0.113 | -0.047 | -0.105 | -0.373 | 0.535 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 0.023 | -0.022 | 0.031 | 0.165 | 0.625 |